[HTML][HTML] Subclinical doxorubicin-induced cardiotoxicity update: role of neutrophils and endothelium
VK Todorova, JY Wei, I Makhoul - American Journal of Cancer …, 2021 - ncbi.nlm.nih.gov
Doxorubicin (DOX) is a highly effective chemotherapy agent that often causes cardiotoxicity.
Despite a number of extensive studies, the risk for DOX cardiotoxicity remains unpredictable …
Despite a number of extensive studies, the risk for DOX cardiotoxicity remains unpredictable …
[HTML][HTML] Guanxin V for coronary artery disease: a retrospective study
B Liang, Y Qu, QF Zhao, N Gu - Biomedicine & Pharmacotherapy, 2020 - Elsevier
Abstract Background Guanxin V (GXV), a traditional herbal mixture, has been widely used in
clinical practice for the treatment of coronary artery disease (CAD). This retrospective study …
clinical practice for the treatment of coronary artery disease (CAD). This retrospective study …
Combined high-density lipoprotein proteomic and glycomic profiles in patients at risk for coronary artery disease
Objectives: To test whether recently developed methods for comprehensive profiling of the
high-density lipoprotein (HDL) glycome combined with the HDL proteome can distinguish …
high-density lipoprotein (HDL) glycome combined with the HDL proteome can distinguish …
The relationship between the new inflammatory markers and disease severity in patients with acute coronary syndrome
Background Inflammation plays a crucial role in the progression of acute coronary
syndrome. Aims The aim of this study was to investigate the relationship between the …
syndrome. Aims The aim of this study was to investigate the relationship between the …
Gene dysregulation in peripheral blood of moyamoya disease and comparison with other vascular disorders
X Peng, Z Zhang, D Ye, P **ng, Z Zou, H Lei, L Duan - PLoS One, 2019 - journals.plos.org
Objective Moyamoya disease (MMD) is a chronic occlusive cerebrovascular disease with
unknown etiology, sharing many similar clinical symptoms with other vascular disorders …
unknown etiology, sharing many similar clinical symptoms with other vascular disorders …
[HTML][HTML] Discovery of plasma biomarkers with data‐independent acquisition mass spectrometry and antibody microarray for diagnosis and risk stratification of …
B Han, C Li, H Li, Y Li, X Luo, Y Liu, J Zhang… - Journal of Thrombosis …, 2021 - Elsevier
Background Pulmonary embolism (PE) is a leading cause of cardiovascular mortality
worldwide. Rapid and accurate diagnosis and risk stratification are crucial for timely …
worldwide. Rapid and accurate diagnosis and risk stratification are crucial for timely …
Serum ischemia modified albumin is a possible new marker of oxidative stress in phenylketonuria
F Keshavarzi, M Rastegar, M Vessal… - Metabolic brain …, 2018 - Springer
The role of oxidative stress in the pathogenesis of phenylketonuria (PKU)-associated
disorders has been implicated. Ischemia modified albumin (IMA) is a modified form of serum …
disorders has been implicated. Ischemia modified albumin (IMA) is a modified form of serum …
Comparative effects of blood and crystalloid cardioplegia on cellular injury and oxidative stress in cardiovascular surgery
Purpose: The purpose of this study was to evaluate the effect of different cardioplegic
solutions on endothelial integrity and oxidative stress in cardiovascular surgery. Methods: In …
solutions on endothelial integrity and oxidative stress in cardiovascular surgery. Methods: In …
[HTML][HTML] The role of decoy receptor 3 in inflammation and atherosclerosis in patients with chronic kidney disease and renal transplant patients
Introduction The cardiovascular risk has been increased in chronic kidney disease
associated with chronic inflammation and atherosclerosis. Decoy receptor 3, is a member of …
associated with chronic inflammation and atherosclerosis. Decoy receptor 3, is a member of …
[HTML][HTML] Derivation and external validation of mass spectrometry-based proteomic model using machine learning algorithms to predict plaque rupture in patients with …
J Wu, K Ma, J Ma, Y Li, Y Ren - Clinica Chimica Acta, 2024 - Elsevier
Background A poor prognosis is associated with atherosclerotic plaque rupture (PR) despite
after conventional therapy for patients with acute coronary syndrome (ACS). Timely …
after conventional therapy for patients with acute coronary syndrome (ACS). Timely …